Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-26 @ 2:09 AM
Study NCT ID:
NCT01650805
Status:
TERMINATED
Last Update Posted:
2014-11-17
First Post:
2012-07-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Sponsor:
Ariad Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AP24534-12-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None